Segway opens preorders on its new Ninebot F3 eKickScooter at $250 off, Anker SOLIX weekend flash sale, Greenworks pressure ...
Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...
Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback